UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000005216
Receipt number R000006197
Scientific Title Randomized phase II trial of FOLFIRI with either panitumumab or bevacizumab as second-line treatment in patients with KRAS wild metastatic colorectal cancer refractory to oxaliplatin and bevacizumab with exploratory analysis to predict treatment efficacy and prognosis
Date of disclosure of the study information 2011/03/08
Last modified on 2017/06/01 09:23:12

No. Disposal Last modified on Item of update
1 Insert 2011/03/08 13:22:51
2 Update 2011/03/25 12:09:33 Name of person sending information
Name of person sending information
3 Update 2011/04/25 13:17:55 Key inclusion criteria
Key exclusion criteria
4 Update 2011/07/28 13:28:45 Public title
5 Update 2011/07/28 13:29:58 Key exclusion criteria
6 Update 2012/07/05 10:55:03 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
7 Update 2012/07/05 10:56:33 Organization
Organization
Division name
Division name
Address
Address
TEL
Post marketing survey by drug manufacture etc., specified by Japanese law.
8 Update 2014/03/06 13:44:04 Recruitment status
9 Update 2017/03/13 09:14:47 Recruitment status
Publication of results
10 Update 2017/06/01 09:23:12 Recruitment status
URL related to results and publications